David Protein Lawsuit: Plaintiffs Home in on Calories From Protein in Final Bid to Make Antitrust Case

Why It Matters

The outcome could set a precedent for antitrust scrutiny of exclusive ingredient control in the fast‑growing food‑tech sector, affecting supply chains and pricing for low‑calorie protein products.

Key Takeaways

• Plaintiffs spent $449k R&D on EPG products now unusable.
• David Protein claims alternative ingredients exist, no supply contract required.
• Judge allowed third amended complaint to clarify market definition.
• Plaintiffs define market as high‑calorie‑from‑protein bars (50‑75% protein).
• Alleged monopoly could sustain 44‑171% price premiums.

Pulse Analysis

EPG, the ultra‑low‑calorie fat replacer developed by Epogee, has become a strategic asset in the protein‑bar market. By delivering only 0.7 calories per gram versus the 9 calories of traditional fat, EPG enables formulators to push protein‑to‑calorie ratios above 50%, a threshold that most competitors cannot reach without compromising texture or taste. This technological edge has spurred a wave of innovation among niche snack makers seeking to market high‑protein, low‑calorie bars to health‑conscious consumers, positioning EPG as a potential game‑changer in a segment projected to grow double‑digit annually.

The antitrust lawsuit centers on whether David Protein’s post‑acquisition control of EPG constitutes an unlawful monopoly. Plaintiffs argue that David’s refusal to supply the ingredient absent long‑term contracts effectively bars rivals from entering the CFP bar market, allowing price premiums of up to 171%. The court’s decision to permit a third amended complaint signals judicial willingness to scrutinize market definition in emerging food‑tech niches, where traditional antitrust metrics may not capture the value of a single, performance‑critical input. Legal experts note that a ruling against David could force the company to license EPG or divest the technology, reshaping competitive dynamics.

Beyond the courtroom, the case highlights broader risks for investors in ingredient‑centric startups. Exclusive control of a proprietary input can create short‑term pricing power but also attracts regulatory attention and potential liability. Companies may need to balance vertical integration with open‑sourcing strategies to mitigate antitrust exposure. For the protein‑bar industry, a decision favoring the plaintiffs could lower barriers to entry, accelerate product diversification, and ultimately benefit consumers seeking affordable, high‑protein snacks.